doesn’t look like a run away gap, so first it’s back to 0.059 unfortunately. Super low volume considering the news and there’s 100 million shares waiting to be sold if we pass the CR price at .066.
Not looking promising at this stage and not holding up any hope for the canine results. I wonder at what discount the next CR comes, and if we want to launch Acne ph 3 we’ll need more cash.
Ann: Positive BTX 1702 Phase 1b/2 Clinical Study for Rosacea, page-30
-
- There are more pages in this discussion • 71 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
36.0¢ |
Change
0.015(4.35%) |
Mkt cap ! $651.6M | |||
| Open | High | Low | Value | Volume |
| 34.5¢ | 36.5¢ | 34.5¢ | $1.175M | 3.288M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 181103 | 35.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.0¢ | 35116 | 5 |
View Market Depth
| Last trade - 15.48pm 22/08/2024 (20 minute delay) ? |
| BOT (ASX) Chart |